Mediators of Inflammation
Volume 2008 (2008), Article ID 534532, 11 pages
doi:10.1155/2008/534532
Research Article

Toll-Like Receptors and Cytokines as Surrogate Biomarkers for Evaluating Vaginal Immune Response following Microbicide Administration

Sadhana M. Gupta, Clara C. Aranha, Madhu C. Mohanty, and K. V. R. Reddy

Immunology Division, National Institute for Research in Reproductive Health, J.M. Street, Parel, Mumbai 400012, India

Received 13 May 2008; Revised 5 August 2008; Accepted 20 August 2008

Academic Editor: Giuseppe Valacchi

Copyright © 2008 Sadhana M. Gupta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. T. Trifonova, J.-M. Pasicznyk, and R. N. Fichorova, “Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 12, pp. 4005–4010, 2006.
  2. R. N. Fichorova, F. Zhou, V. Ratnam, et al., “Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 1, pp. 323–335, 2005.
  3. M. Alfano and G. Poli, “The cytokine network in HIV infection,” Current Molecular Medicine, vol. 2, no. 8, pp. 677–689, 2002.
  4. A. Stone, “Microbicides: the UNAIDS-sponsored trial of nonoxynol-9 gel,” IPPF Medical Bulletin, vol. 34, no. 3, pp. 3–4, 2000.
  5. P. M. Rowe, “Nonoxynol-9 fails to protect against HIV-1,” The Lancet, vol. 349, no. 9058, p. 1074, 1997.
  6. M. K. Stafford, H. Ward, A. Flanagan, et al., “Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 17, no. 4, pp. 327–331, 1998.
  7. M. B. Dayal, J. Wheeler, C. J. Williams, and K. T. Barnhart, “Disruption of the upper female reproductive tract epithelium by nonoxynol-9,” Contraception, vol. 68, no. 4, pp. 273–279, 2003.
  8. K. V. R. Reddy, C. Aranha, S. M. Gupta, and R. D. Yedery, “Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies,” Reproduction, vol. 128, no. 1, pp. 117–126, 2004.
  9. K. V. R. Reddy, R. D. Yedery, and C. Aranha, “Antimicrobial peptides: premises and promises,” International Journal of Antimicrobial Agents, vol. 24, no. 6, pp. 536–547, 2004.
  10. E. Breukink and B. de Kruijff, “The lantibiotic nisin, a special case or not?,” Biochimica et Biophysica Acta, vol. 1462, no. 1-2, pp. 223–234, 1999.
  11. J. N. Hansen, “Nisin and related antimicrobial peptides,” in Biotechnology of Antibiotics, W. R. Strohl, Ed., pp. 437–470, Marcel Dekker, New York, NY, USA, 1997.
  12. C. C. Aranha, S. M. Gupta, and K. V. R. Reddy, “Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits,” Cytokine, vol. 43, no. 1, pp. 63–70, 2008.
  13. F. Bäckhed and M. Hornef, “Toll-like receptor 4-mediated signaling by epithelial surfaces: necessity or threat?,” Microbes and Infection, vol. 5, no. 11, pp. 951–959, 2003.
  14. S. Basu and M. J. Fenton, “Toll-like receptors: function and roles in lung disease,” American Journal of Physiology, vol. 286, no. 5, pp. L887–L892, 2004.
  15. A. Bowie and L. A. J. O'Neill, “The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products,” Journal of Leukocyte Biology, vol. 67, no. 4, pp. 508–514, 2000.
  16. X. Du, A. Poltorak, Y. Wei, and B. Beutler, “Three novel mammalian toll-like receptors: gene structure, expression, and evolution,” European Cytokine Network, vol. 11, no. 3, pp. 362–371, 2000.
  17. T.-H. Chuang and R. J. Ulevitch, “Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells,” Biochimica et Biophysica Acta, vol. 1518, no. 1-2, pp. 157–161, 2001.
  18. N. J. Gay and F. J. Keith, “Drosophila Toll and IL-1 receptor,” Nature, vol. 351, no. 6325, pp. 355–356, 1991.
  19. K. Takeda and S. Akira, “Toll-like receptors in innate immunity,” International Immunology, vol. 17, no. 1, pp. 1–14, 2005.
  20. S. Uematsu and S. Akira, “Toll-like receptors and innate immunity,” Journal of Molecular Medicine, vol. 84, no. 9, pp. 712–725, 2006.
  21. X.-D. Yao, S. Fernandez, M. M. Kelly, C. Kaushic, and K. L. Rosenthal, “Expression of Toll-like receptors in murine vaginal epithelium is affected by the estrous cycle and stromal cells,” Journal of Reproductive Immunology, vol. 75, no. 2, pp. 106–119, 2007.
  22. V. M. Abrahams, “Toll-like receptors in the cycling female reproductive tract and during pregnancy,” Current Women's Health Reviews, vol. 1, no. 1, pp. 35–42, 2005.
  23. R. N. Fichorova, M. Bajpai, N. Chandra, et al., “Interleukin (IL)-1, IL-6 and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives,” Biology of Reproduction, vol. 71, no. 3, pp. 761–769, 2004.
  24. S. M. Gupta, C. C. Aranha, and K. V. R. Reddy, “Evaluation of developmental toxicity of microbicide Nisin in rats,” Food and Chemical Toxicology, vol. 46, no. 2, pp. 598–603, 2008.
  25. C. R. Wira, J. V. Fahey, C. L. Sentman, P. A. Pioli, and L. Shen, “Innate and adaptive immunity in female genital tract: cellular responses and interactions,” Immunological Reviews, vol. 206, no. 1, pp. 306–335, 2005.
  26. S. Tabibzadeh, “Ubiquitous expression of TNF-α/cachectin immunoreactivity in human endometrium,” American Journal of Reproductive Immunology, vol. 26, no. 1, pp. 1–4, 1991.
  27. A. R. Neurath, N. Strick, and Y.-Y. Li, “Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides,” BMC Infectious Diseases, vol. 2, article 27, pp. 1–11, 2002.
  28. S. L. Lard-Whiteford, D. Matecka, J. J. O'Rear, I. S. Yuen, C. Litterst, and P. Reichelderfer, “Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update,” Journal of Acquired Immune Deficiency Syndromes, vol. 36, no. 1, pp. 541–552, 2004.
  29. M. J. Keller, E. Guzman, E. Hazrati, et al., “PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity,” AIDS, vol. 21, no. 4, pp. 467–476, 2007.
  30. A. M. Cole and A. L. Cole, “Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense,” American Journal of Reproductive Immunology, vol. 59, no. 1, pp. 27–34, 2008.
  31. L. Alexopoulou, A. C. Holt, R. Medzhitov, and R. A. Flavell, “Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3,” Nature, vol. 413, no. 6857, pp. 732–738, 2001.
  32. A. Fazeli, C. Bruce, and D. O. Anumba, “Characterization of Toll-like receptors in the female reproductive tract in humans,” Human Reproduction, vol. 20, no. 5, pp. 1372–1378, 2005.
  33. R. N. Fichorova, A. O. Cronin, E. Lien, D. J. Anderson, and R. R. Ingalls, “Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of Toll-like receptor 4-mediated signaling,” The Journal of Immunology, vol. 168, no. 5, pp. 2424–2432, 2002.
  34. G. Köllisch, B. N. Kalali, V. Voelcker, et al., “Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes,” Immunology, vol. 114, no. 4, pp. 531–541, 2005.
  35. F. Vernel-Pauillac and F. Merien, “Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans,” Infection and Immunity, vol. 74, no. 7, pp. 4172–4179, 2006.
  36. J. E. Girling and M. P. Hedger, “Toll-like receptors in the gonads and reproductive tract: emerging roles in reproductive physiology and pathology,” Immunology & Cell Biology, vol. 85, no. 6, pp. 481–489, 2007.
  37. T. Ganz, “Immunology: versatile defensins,” Science, vol. 298, no. 5595, pp. 977–979, 2002.
  38. T. Ganz, “Defensins: antimicrobial peptides of innate immunity,” Nature Reviews Immunology, vol. 3, no. 9, pp. 710–720, 2003.
  39. N. W. J. Schröder and M. Arditi, “The role of innate immunity in the pathogenesis of asthma: evidence for the involvement of Toll-like receptor signaling,” Journal of Endotoxin Research, vol. 13, no. 5, pp. 305–312, 2007.
  40. E. LeBouder, J. E. Rey-Nores, N. K. Rushmere, et al., “Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk,” The Journal of Immunology, vol. 171, no. 12, pp. 6680–6689, 2003.